Morgan Stanley’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29K | Buy |
3,500
+3,400
| +3,400% | +$2.23K | ﹤0.01% | 7199 |
|
|
2025
Q1 | $61 | Sell |
100
-127
| -56% | -$77 | ﹤0.01% | 7661 |
|
|
2024
Q4 | $238 | Buy |
+227
| New | +$238 | ﹤0.01% | 7397 |
|
|
2022
Q4 | – | Sell |
-17,057
| Closed | -$19K | – | 7902 |
|
|
2022
Q3 | $19K | Buy |
17,057
+7,057
| +71% | +$7.86K | ﹤0.01% | 6816 |
|
|
2022
Q2 | $21K | Hold |
10,000
| – | – | ﹤0.01% | 6953 |
|
|
2022
Q1 | $22K | Buy |
10,000
+5,000
| +100% | +$11K | ﹤0.01% | 7101 |
|
|
2021
Q4 | $13K | Buy |
+5,000
| New | +$13K | ﹤0.01% | 7370 |
|